SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-040500
Filing Date
2019-08-19
Accepted
2019-08-19 08:01:12
Documents
3
Period of Report
2019-08-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv527820_8k.htm 8-K 21705
2 EXHIBIT 99.1 tv527820_ex99-1.htm EX-99.1 11641
3 GRAPHIC image_001.jpg GRAPHIC 17354
  Complete submission text file 0001144204-19-040500.txt   58724
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 191034944
SIC: 2834 Pharmaceutical Preparations